Scientific support and regulatory guidance to get nutraceutical
finished products or raw materials ready for the US market.

Education

  • PhD Inorganic Chemistry – University of Bordeaux, France
  • Master’s Foods & Nutrition – University of Utah, Salt Lake City
  • Registered Dietitian – Currently licensed

Awards

  • Small Business Investigator Award – 3/1/93-8/15/93
  • NIH Award No 1-R43-CA59074-01
  • “Effect of Enteral formulas on Cyclophosphamide and 5-Fluorouracil Toxicity”.
  • Research Grant Fellowship  – 9/91-6/92
  • University of Utah.
  • “Effect of Enteral formulas on Methotrexate Toxicity”.
  • Outstanding Graduate Student in Academics – 1992

Publications and Presentations

  • J. Ehrenkranz, N. Chevreau, S. Alder, and J. Roth. Oral phlorizin, an inhibitor of active glucose transport, blunts the postprandial glucose and insulin rise in humans. P3-411. ENDO 05, June 6, 2005, San Diego, CA.
  • N. Chevreau, P. Anthony and K. Kessinger. Managing Hyperemesis Gravidarum with Home Parenteral Nutrition: Treatment Parameters and Clinical Outcomes. Infusion. 5(8), 22-28, May 1999.
  • N. Chevreau, K. Kessinger and P. Anthony: Incidence of IV lipid intolerance in Hyperemesis Gravidarum on Home TPN. Presented at the Aspen 23rd Clinical Congress. Jan 31-Feb 3, 1999.
  • N. Chevreau: Pregnancy outcome of patients with Hyperemesis Gravidarum receiving TPN. Presented at the ASPEN 22nd Clinical Congress. Jan 18-21, 1998.
  • B. Meierhofer and N. Chevreau: Subcutaneous Reglan therapy for nausea/vomiting in Hyperemesis Gravidarum. Presented at the NAVAN National conference. Philadelphia, Sept 17-20, 1997.
  • N. Chevreau and M. Funk-Archuleta: Effect of enteral formulas on methotrexate toxicity. Nutrition and Cancer. 23:2, 185-204, 1995.
  • N. Chevreau, Y. Wang and M. Funk-Archuleta: Effect of diets on 5-fluorouracil and cyclophosphamide toxicity. Nutrition and Cancer. 23:2, 205-220, 1995.
  • Y. Wang, M. Funk, K. Garleb, and N. Chevreau: The effect of fiber source in enteral products on fecal weight, mineral balance, and growth rate in rats. JPEN. 18:4, 340-345, 1994.
  • N. Chevreau and M. Funk-Archuleta: Effect of enteral formulas on methotrexate toxicity. Abstract presented at FASEB, April 1994.
  • J.K. Weeks, N. Chevreau, Jared Lee Sommer, and Joel Sommer: The manufacture of high Tc superconducting composite wires. Phase II SBIR Final Report. Naval Surface Warfare Center Award No N60921-90-C-0106, May 2, 1992.
  • J.K. Weeks, N. Chevreau, and R.L. Seeley: Graphite reinforced copper alloys for fusion reactors application. Phase II SBIR Final Report. DOE Award No DE-AC02-87ER80504, October 16, 1991.
  • J.K. Weeks, and N. Chevreau: Titanium nitride reaction mechanisms. Phase II SBIR Final Report. NSF Award No ISI-8701749, Sept. 30, 1991.
  • J.K. Weeks, N. Chevreau: Copper infiltrated graphite for improved brazed joints. Fusion Technology. 19, 1772, 1991.
  • J.K. Weeks, N. Chevreau, and R. Seeley: Copper infiltrated graphite for improved brazed joints. Phase I SBIR Final Report, DOE Award No DE-AC02-89ER80789, April 24, 1990.
  • J.K. Weeks, C. Gensse, and N. Chevreau: Graphite Reinforced Aluminum Composite by Liquid Metal Infiltration. Phase I SBIR Final Report, NSWC Award No N60921-89-C-0176, February 15, 1990.
  • J.K. Weeks, N. Chevreau: Silicon Nitride. Phase I SBIR Final Report, NSF Award No ISI-8760932, July 31, 1988.
  • N. Chevreau, and D. Johnson D.: Preparation and physical properties of BiMO6S8 and SbMO6S8. J. Solid State Chemistry, 61, 347, 1986.
  • J.L. Soubeyroux J.L., and N. Chevreau: Neutron diffraction in the study of Sr0.5La1.5Li0.5Fe0.504. J. Solid State Chem., 50, 2977, 1983.
  • J.L. Soubeyroux, N. Chevreau, B. Buffat, and G. Demazeau: Magnetic properties of oxides containing six-coordinated iron (IV) and (V). Physica, 120B, 227 1983.
  • G. Demazeau, N. Chevreau, and B. Buffat: Coexistence of six-coordinated high spin iron (IV) and low spin Ni (III) in an oxygen lattice. C.R. Acad. SC. Paris, 295, 661, 1982.